Experiment 1155276

Details

PropertyValue
Pharmacology
Administration routeIV INFUSION
OrganismEmpty organism
CitationCREAGAN,ET: EDMONSON,JH: AHMANN,DL: CHANG,M:. (1985). PHASE II STUDY OF MITOMYCIN IN DISSEMINATED MALIGNANT MELANOMA.. 69(12)
Amount utilized
Compound isolated
DiseaseIN THIS PHASE II STUDY, 26 PATIENTS WITH MALIGNANT MELANOMA WERE TREATED WITH MITOMYCIN EVERY SIX WEEKS. THERE WAS ONE COMPLETE RESPONSE, IN A POOR RISK PATIENT WHO HAD HAD PRIOR CHEMOTHERAPY. MILD NAUSEA AND VOMITING AFFECTED 9% OF THE PATIENTS. MYELOSUPPRESSION WAS THE DOSE LIMITING TOXICITY.
Dose amount15.0 MG
Number1
Qualitative resultEQUIVOCAL
AnimalHUMAN ADULT
Per unitSQ M BODY SURFACE
Dose expressionDOSE